FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Alizon

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Concepts & Ideas

Molecular Sequence Data

Physiology

Disorders

Acquired Immunodeficiency Syndrome

Co-author Network

Publications

TOP 3
Maurine Delhaye; Audrey Gravot; Diana Ayinde; Florence Niedergang; Marc Alizon; Anne Brelot
Identification of a postendocytic sorting sequence in CCR5.
Séverine Bär; Ayato Takada; Yoshihiro Kawaoka; Marc Alizon
Detection of cell-cell fusion mediated by Ebola virus glycoproteins.
Julie Lemay; Stefano Marullo; Ralf JOckers; Marc Alizon; Anne Brelot
On the dimerization of CCR5.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Alizon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Maurine Delhaye; Audrey Gravot; Diana Ayinde; Florence Niedergang; Marc Alizon; Anne Brelot
Identification of a postendocytic sorting sequence in CCR5.
Molecular pharmacology 2007;72(6):1497-507.
2006: Séverine Bär; Ayato Takada; Yoshihiro Kawaoka; Marc Alizon
Detection of cell-cell fusion mediated by Ebola virus glycoproteins.
Journal of virology 2006;80(6):2815-22.
2005: Julie Lemay; Stefano Marullo; Ralf JOckers; Marc Alizon; Anne Brelot
On the dimerization of CCR5.
Nature immunology 2005;6(6):535; author reply 535-6.
2005: Kirilee A Wilson; Séverine Bär; Anne L Maerz; Marc Alizon; Pantelis Poumbourios
The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.
Journal of virology 2005;79(7):4533-9.
2004: Oliver Hartley; Hubert Gaertner; Jill Wilken; Darren Thompson; Richard Fish; Alejandra Ramos; Cristina Pastore; Brigitte Dufour; Fabrice Cerini; Astrid Melotti; Nikolaus Heveker; Laurent Picard; Marc Alizon; Donald E Mosier; Stephen Kent; Robin E Offord
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(47):16460-5.
2004: Séverine Bär; Marc Alizon
Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
Journal of virology 2004;78(2):811-20.
2002: Maurice Chelli; Marc Alizon
Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor.
The Journal of biological chemistry 2002;277(42):39388-96.
2001: M Chelli; Marc Alizon
Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.
The Journal of biological chemistry 2001;276(50):46975-82.
2001: Frédéric Baribaud; Terri G Edwards; Matthew Sharron; Anne Brelot; Nikolaus Heveker; K Price; Frank Mortari; Marc Alizon; Monica Tsang; Robert W Doms
Antigenically distinct conformations of CXCR4.
Journal of virology 2001;75(19):8957-67.
2001: B Labrosse; C Treboute; Anne Brelot; Marc Alizon
Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Journal of virology 2001;75(12):5457-64.
2001: Nikolaus Heveker; M Tissot; Alain Thuret; Jens Schneider-Mergener; Marc Alizon; M Roch; Stefano Marullo
Pharmacological properties of peptides derived from stromal cell-derived factor 1: study on human polymorphonuclear cells.
Molecular pharmacology 2001;59(6):1418-25.
2001: Anne Brelot; Marc Alizon
HIV-1 entry and how to block it.
AIDS (London, England) 2001;15 Suppl 5():S3-11.
2001: Virginie Trouplin; Francesca Salvatori; F Cappello; Véronique Obry; Anne Brelot; Nikolaus Heveker; Marc Alizon; Gabriella Scarlatti; François Clavel; Fabrizio Mammano
Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay.
Journal of virology 2001;75(1):251-9.
2000: Anne Brelot; Nikolaus Heveker; M Montes; Marc Alizon
Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
The Journal of biological chemistry 2000;275(31):23736-44.
2000: B Labrosse; C Treboute; Marc Alizon
Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region.
Journal of virology 2000;74(5):2142-50.
1999: Jennifer Richardson; Gianfranco Pancino; R Merat; Thierry Leste-Lasserre; Anne Moraillon; Jens Schneider-Mergener; Marc Alizon; Pierre Sonigo; Nikolaus Heveker
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
Journal of virology 1999;73(5):3661-71.
1999: Anne Brelot; Nikolaus Heveker; K Adema; Margaret J Hosie; Brian J Willett; Marc Alizon
Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.
Journal of virology 1999;73(4):2576-86.
1998: Brian J Willett; K Adema; Nikolaus Heveker; Anne Brelot; Laurent Picard; Marc Alizon; JD Turner; James A Hoxie; Stephen Peiper; James C Neil; Margaret J Hosie
The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.
Journal of virology 1998;72(8):6475-81.
1998: O Pleskoff; C Tréboute; Marc Alizon
The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins.
Journal of virology 1998;72(8):6389-97.
1998: B Labrosse; Anne Brelot; Nikolaus Heveker; N Sol; D Schols; E De Clercq; Marc Alizon
Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.
Journal of virology 1998;72(8):6381-8.
1998: Jacqueline D Reeves; Nikolaus Heveker; Anne Brelot; Marc Alizon; Paul R Clapham; Laurent Picard
The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2.
The Journal of general virology 1998;79 ( Pt 7)():1793-9.
1998: Nikolaus Heveker; M Montes; Lothar Germeroth; A Amara; A Trautmann; Marc Alizon; Jens Schneider-Mergener
Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
Current biology : CB 1998;8(7):369-76.
1998: N Sol; C Tréboute; E Gomas; F Ferchal; Barbara L Shacklett; Marc Alizon
The rhesus macaque CCR3 chemokine receptor is a cell entry cofactor for HIV-2, but not for HIV-1.
Virology 1998;240(2):213-20.
1997: N Sol; F Ferchal; J Braun; O Pleskoff; C Tréboute; I Ansart; Marc Alizon
Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2.
Journal of virology 1997;71(11):8237-44.
1997: B Labrosse; O Pleskoff; N Sol; C Jones; Y Hénin; Marc Alizon
Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.
Journal of virology 1997;71(11):8230-6.
1997: S Ugolini; Maxime Moulard; I Mondor; N Barois; D Demandolx; James A Hoxie; Anne Brelot; Marc Alizon; Jean Davoust; Quentin J Sattentau
HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):3000-8.
1997: O Pleskoff; C Tréboute; Anne Brelot; Nikolaus Heveker; M Seman; Marc Alizon
Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry.
Science (New York, N.Y.) 1997;276(5320):1874-8.
1997: Anne Brelot; Nikolaus Heveker; O Pleskoff; N Sol; Marc Alizon
Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.
Journal of virology 1997;71(6):4744-51.
1997: O Pleskoff; N Sol; B Labrosse; Marc Alizon
Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).
Journal of virology 1997;71(4):3259-62.
1996: O Pleskoff; N Sol; H Marrakchi; M Serlin; M Seman; Marc Alizon
Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry.
Journal of virology 1996;70(11):8247-51.
1995: T Dragic; L Picard; Marc Alizon
Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.
Journal of virology 1995;69(2):1013-8.
1995: O Pleskoff; M Seman; Marc Alizon
Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.
Journal of virology 1995;69(1):570-4.
1994: I Lazaro; D Naniche; N Signoret; A M Bernard; D Marguet; D Klatzmann; T Dragic; Marc Alizon; Quentin J Sattentau
Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.
Journal of virology 1994;68(10):6535-46.
1994: Marc Alizon; T Dragic
CD26 antigen and HIV fusion?
Science (New York, N.Y.) 1994;264(5162):1161-2; author reply 1162-5.
1994: Olivier Schwartz; Marc Alizon; Jean Michel Heard; O Danos
Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein.
Virology 1994;198(1):360-5.
1993: N Sol; Frédéric Morinet; Marc Alizon; U Hazan
Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
The Journal of general virology 1993;74 ( Pt 9)():2011-4.
1993: T Dragic; Marc Alizon
Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
Journal of virology 1993;67(4):2355-9.
1992: T Dragic; Pierre Charneau; François Clavel; Marc Alizon
Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
Journal of virology 1992;66(8):4794-802.
1992: Pierre Charneau; Marc Alizon; François Clavel
A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication.
Journal of virology 1992;66(5):2814-20.
1987: L Chakrabarti; M Guyader; Marc Alizon; M D Daniel; R C Desrosiers; Pierre Tiollais; Pierre Sonigo
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.
Nature 1987;328(6130):543-7.
1987: M Guyader; M Emerman; Pierre Sonigo; François Clavel; Luc Montagnier; Marc Alizon
Genome organization and transactivation of the human immunodeficiency virus type 2.
Nature 1987;326(6114):662-9.
1987: Françoise Brun Vezinet; M A Rey; C Katlama; Pierre-Marie Girard; D Roulot; P Yeni; L Lenoble; François Clavel; Marc Alizon; S Gadelle
Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients.
Lancet 1987;1(8525):128-32.
1987: Marc Alizon; Luc Montagnier
Genetic variability in human immunodeficiency viruses.
Annals of the New York Academy of Sciences 1987;511():376-84.
1986: François Clavel; M Guyader; Denise Guétard; M Sallé; Luc Montagnier; Marc Alizon
Molecular cloning and polymorphism of the human immune deficiency virus type 2.
Nature 1986;324(6098):691-5.
1986: Marc Alizon; S Wain-Hobson; Luc Montagnier; Pierre Sonigo
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.
Cell 1986;46(1):63-74.
1985: Pierre Sonigo; Marc Alizon; KA Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.
Cell 1985;42(1):369-82.
1985: S Wain-Hobson; Pierre Sonigo; O Danos; S Cole; Marc Alizon
Nucleotide sequence of the AIDS virus, LAV.
Cell 1985;40(1):9-17.
1984: Marc Alizon; Pierre Sonigo; F Barré-Sinoussi; J C Chermann; P Tiollais; Luc Montagnier; S Wain-Hobson
Molecular cloning of lymphadenopathy-associated virus.
Nature 1984;312(5996):757-60.
1984: Luc Montagnier; J C Chermann; F Barré-Sinoussi; D Klatzmann; S Wain-Hobson; Marc Alizon; François Clavel; Françoise Brun Vezinet; E Vilmer; C Rouzioux
Lymphadenopathy associated virus and its etiological role in AIDS.
Princess Takamatsu symposia 1984;15():319-31.